
Media
Orphan cell and gene therapies more likely to reach approval than larger drug pipeline: study
Article featured in Fierce Biotech

MEDIA
Value creators or financial destroyers? The potential of gene therapies to transform healthcare
Article featured in STAT

New research brief: Analyzing 340B and ASP interactions: Do Federal program rules disincentivize the use of VBCs, despite Medicaid Best Price reform?
Our new work describes the interactions among Medicaid Best Price rebate calculations and those for 340B Ceiling Prices and Average Sales Prices which can create disincentives for providers and therapy developers from the use of Value-Based Contracts.


A practical approach for defining outcomes and thresholds for predictive healthcare algorithm development using real-world data
As the healthcare system evolves towards value-based care, predictive algorithms can play a critical role, but their findings must be perceived as meaningful, substantial, and actionable by those outside the data science community.
